• Kelley Anderson MD, FACC

  • Physician - Cardiology

    • Cardiology
    • 1000 North Oak Ave. 2D2 Marshfield, WI 54449


1980 to 1983:
Fellowship, Cardiology, Stanford University School of Medicine, Stanford, CA
1978 to 1980:
Residency, Internal Medicine, University of Chicago-Hospitals, Michael Reese Hospital and Medical Center, Chicago, IL
1977 to 1978:
Internship, Internal Medicine, University of Chicago-Hospitals, Michael Reese Hospital and Medical Center, Chicago, IL
1973 to 1977:
MD, University of Rochester School of Medicine and Dentistry, Rochester, NY
1969 to 1973:
BA, Psychology, University of Rochester College of Arts and Sciences, Rochester, NY
1971 to 1972:
Hull University, Hull, England

Work Experience

2010 to Present:
Adjunct Clinical Professor of Medicine, University of Wisconsin Medical School, Madison, WI
2000 to Present:
Cardiologist, Marshfield Clinic, Marshfield, WI
2000 to Present:
Attending Physician, Marshfield Medical Center - Marshfield, Marshfield, WI
2010 to 2012:
Director, Heart Failure Program, Marshfield Clinic, Marshfield, WI
2009 to 2011:
Medical Director Heart Care Services, Ministry Saint Joseph's Hospital, Marshfield, WI
2009 to 2011:
Chair, Department of Cardiology, Marshfield Clinic, Marshfield, WI
2001 to 2010:
Clinical Associate Professor of Medicine, University of Wisconsin Medical School, Madison, WI
1994 to 2000:
Director, Cardiac Electrophysiology Program, University of Pittsburgh Medical Center and Pittsburgh Veterans Administration Medical Center, Pittsburgh, PA
1994 to 2000:
Associate Professor, University of Pittsburgh School of Medicine, Pittsburgh, PA
1991 to 1994:
Associate Professor, University of Utah School of Medicine, Salt Lake City, UT
1983 to 1994:
Director, Clinical Electrophysiology Laboratory and Cardiac Research Laboratory, University of Utah School of Medicine, Salt Lake City, UT
1983 to 1991:
Assistant Professor, University of Utah School of Medicine, Salt Lake City, UT

Board Certifications

1980 to Present:
Internal Medicine
1983 to Present:
Cardiovascular Diseases
2010 to Present:
Cardiovascular Computed Tomography
2016 to Present:
Clinical Cardiac Electrophysiology (1996, Recertified 2006), Recertified

Professional Societies

American Heart Association, Basic Science Council, Member
American College of Cardiology, Fellow
American Federation for Clinical Research, Member
American College of Physicians, Fellow
Cardiac Electrophysiology Society, Member
Heart Rhythm Society, Fellow
American Society of Echocardiography, Member
Society of Cardiovascular Computed Tomography, Member

Select Publications

  • Anderson KP, DeCamilla J, Moss AJ. (1978 May). Clinical significance of ventricular tachycardia (3 beats or longer) detected during ambulatory monitoring after myocardial infarction. CIRCULATION. 57(5):890-897.
    PubMed ID: 639211
  • Anderson KP, Stinson EB, Mason JW. (1982 March). Surgical exclusion of focal paroxysmal atrial tachycardia. Am J Cardiol. 49(4):869-874.
    PubMed ID: 7064836
  • Nash E, Beinlich I, Anderson KP, Mason JW. (1982). A computerized electrophysiology analysis system. Computers in Cardiology. :1-4.
  • Anderson KP, Stinson EB, Derby GC, Oyer PE, Mason JW. (1983 March). Vulnerability of patients with obstructive hypertrophic cardiomyopathy to ventricular arrhythmia induction in the operating room. Analysis of 17 patients. Am J Cardiol. 51(5):811-816.
    PubMed ID: 6681930
  • Fogoros RN, Anderson KP, Winkle RA, Swerdlow CD, Mason JW. (1983 July). Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. CIRCULATION. 68(1):88-94.
    PubMed ID: 6851057
  • Anderson KP, Mason JW. (1983 September). Surgical management of ventricular tachyarrhythmias. Clin Cardiol. 6(9):415-425.
    PubMed ID: 6354539
  • Anderson KP, Swerdlow CD, Mason JW. (1984 January). Entrainment of ventricular tachycardia. Am J Cardiol. 53(2):335-340.
    PubMed ID: 6695734
  • Anderson KP. (1984). Sudden death in patients with hypertrophic cardiomyopathy. Cardiovasc Rev and Rep. 5 :363-377.
  • Anderson KP, Mason JW. (1984). Mechanisms of ventricular tachycardia. Le Journal International de Medicine. 9 :12-19.
  • Anderson KP. (1984). Sudden death, hypertension, and hypertrophy. J Cardiovasc Pharmacol. 6(Suppl 3):S498-S503.
    PubMed ID: 6208419
  • Mason JW, Stinson EB, Oyer PE, Winkle RA, Hunt S, Anderson KP, Derby GC. (1985 June). The mechanisms of ventricular tachycardia in humans determined by intraoperative recording of the electrical activation sequence. Int J Cardiol. 8(2):163-175.
    PubMed ID: 4008106
  • Anderson KP, Stinson EB, Block PJ, Derby GC, Oyer PE, Ross DL,...Mason JW. (1986). Epicardial mapping in patients with hypertrophic cardiomyopathy. J Applied Cardiol. 1 :285-307.
  • Anastasiou-Nana MI, Anderson JL, Nanas JN, Lutz JR, Smith RA, Anderson KP,...Call NB. (1986 May). High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias. Can J Cardiol. 2(3):138-145.
    PubMed ID: 2941121
  • Green LS, Lux RL, Freedman RA, Anderson KP, Haws CW. (1986). Body surface QRST areas and therapy for long QT syndrome. Clin Res. :34-2D304A.
  • Freedman RA, Anderson KP, Mason JW. (1986). Electrophysiologic studies in patients with ventricular tachycardia. Annu Rev Med. 37 :1-12.
    PubMed ID: 3518600
  • Anderson KP, Freedman RA, Mason JW. (1986). Electrophysiologic study: when is it appropriate? Drug Therapy. 16 :111-126.
  • Mason JW, Anderson KP, Freedman RA. (1987 April). Techniques and criteria in electrophysiologic study of ventricular tachycardia. CIRCULATION. 75(4 Pt 2):III125-133.
    PubMed ID: 3549047
  • Freedman RA, Anderson KP, Green LS, Mason JW. (1987 January). Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. Am J Cardiol. 59(1):168-169.
    PubMed ID: 3812231
  • Anderson KP, Freedman RA, Mason JW. (1987 July). Sudden death in idiopathic dilated cardiomyopathy. Ann Intern Med. 107(1):104-106.
    PubMed ID: 3592423
  • Anderson KP. (1989 June). The ESVEM trial. Electrophysiologic Study Versus Electrocardiographic Monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias. The ESVEM Investigators. CIRCULATION. 79(6):1354-1360.
    PubMed ID: 2655967
  • Anderson KP, Walker R, Dustman T, Lux RL, Ershler PR, Kates RE, Urie P. (1989 April). Rate-related electrophysiologic effects of long-term administration of amiodarone on canine ventricular myocardium in vivo. CIRCULATION. 79(4):948-958.
    PubMed ID: 2924420
  • Lux RL, Ershler PR, Anderson KP, Mason JW. (1989). Rapid localization of accessory pathways in WPW syndrome using unipolar potential mappiong. Proc of IEEE Eng, Med & Biol Soc. :195-196.
  • Anderson KP, Walker R, Lux RL, Ershler PR, Menlove R, Williams MR,...Moddrelle D. (1990 March). Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart. CIRCULATION. 81(3):1024-1038.
    PubMed ID: 2155070
  • Anderson KP. (1990). Sudden death in patients with hypertrophic cardiomyopathy: recent developments. Cardiovasc Rev Rep. 11 :66-75.
  • Anderson KP, Lux RL, Dustman T. (1990 June). Comparison of QRS morphologies of spontaneous premature ventricular complexes and ventricular tachycardia induced by programmed stimulation. AMERICAN HEART JOURNAL. 119(6):1302-11.
    PubMed ID: 1693809
  • Anderson KP, Walker R, Ershler PR, Fuller M, Dustman T, Menlove R,...Lux RL. (1991 October). Determination of local myocardial electrical activation for activation sequence mapping. A statistical approach. Circ Res. 69(4):898-917.
    PubMed ID: 1934344
  • Anderson KP, Walker R, Fuller M, Dustman T, Ershler PR, Lux RL. (1993 February). Criteria for local myocardial electrical activation: effects of electrogram characteristics. IEEE Trans Biomed Eng. 40(2):1-13.
    PubMed ID: 8319968
  • Anderson KP. (1993 February). Determinants of predicted efficacy of antiarrhythmic drugs in the electrophysiologic study versus electrocardiographic monitoring trial. The ESVEM Investigators. CIRCULATION. 87(2):323-329.
    PubMed ID: 8425281
  • Anderson KP. (1993 July). Management of ectopic atrial tachycardia. J Am Coll Cardiol. 22(1):93-94.
    PubMed ID: 8509570
  • Anderson KP, Walker R, Urie P, Ershler PR, Lux RL, Karwandee SV. (1993 July). Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy. J Clin Invest. 92(1):122-140.
    PubMed ID: 8325977
  • Anderson KP. (1993). A randomized comparison of electrophysiologic study to electrocardiographic monitoring for prediction of antiarrhythmic drug efficacy in patients with ventricular tachyarrhythmias. ESVEM Investigators. N Engl J Med. 329 :445-451.
  • Anderson KP. (1993). A comparison of seven antiarrhythmic drugs in patients with ventricular tacharrhythmias. ESVEM Investigators. N Engl J Med. 329 :452-458.
  • Anderson KP. (1995). The electrophysiologic study versus electrocardiographic monitoring trial and the role of electrophysiologic study in the management of pateints with ventricular tachyarrhythmias. J Ambulatory Monitoring. 8 :185-196.
  • Anderson KP, Schloss EJ. (1995). The ESVEM trial tells us what we don't know (letter). CIRCULATION. :3144.
  • Anderson KP, Walker R, Dustman T, Fuller M, Mori M. (1995 August). Spontaneous sustained ventricular tachycardia in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 26(2):489-96.
    PubMed ID: 7541813
  • Anderson KP, Bigger JT, Freedman RA. (1996). The clinical significance of nonsustained ventricular tachycardia in patients with sustained centricular tachyarrhythmias. Ann Noninvasive Electrocardiol. 1 :33-43.
  • Anderson KP, Bigger JT, Freedman RA. (1996 May). Electrocardiographic predictors in the ESVEM trial: unsustained ventricular tachycardia, heart period variability, and the signal-averaged electrocardiogram. Prog Cardiovasc Dis. 38(6):463-488.
    PubMed ID: 8638028
  • Anderson KP, Hartz V, Hahn EA, Moon TE. (1996 May). Design and analysis of the ESVEM Trial. Prog Cardiovasc Dis. 38(6):489-502.
    PubMed ID: 8638029
  • Anderson KP, Mori M. (1996). The clinical significance of nonsustained ventricular tachycardia in patients with sustained ventricular tachyarrhythmias. Ann Noninvasive Electrocardiol. 1 :33-43.
  • Anderson KP, Bigger JT, Hammill SC, Lamas GA, Lazzara A, Malik M,...Roden DM. (1997). Who needs a journal? Cardiac Electrophysiol Rev. 1 :1.
  • Wanless RS, Anderson KP, Joy M, Joseph SP. (1997 April). Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias. Am Heart J. 133(4):441-446.
    PubMed ID: 9124166
  • Shusterman V, Anderson KP, Barnea O. (1997 September). Spontaneous skin temperature oscillations in normal human subjects. Am J Physiol. 273(3 Pt 2):R1173-R1181.
    PubMed ID: 9321901
  • Shusterman V, Konety S, Flanigan S, Shah SI, Fahrig S, Gottipaty V, Anderson KP. (1997). Short-term changes in RR and QT-intervals are related to the rate and duration of ventricular tachycardia. CIRCULATION. 96 (Suppl - I) :I-581.
  • Gold MR, Kavesh NG, Anderson KP, Bloomfield DM, Estes NMark, Michaud GF,...Rosenbaum DS. (1998). Correlation of T-wave alternans during exercise with the induction of ventricular tachycardia. PACE Pacing Clin Electrophysiol. 21 :861.
  • Shusterman V, Li C, Aysin B, Brode S, Fahrig S, Gottipaty V,...Anderson KP. (1998). ircadian changes in the energy distribution of wavelet-transformed heart rate variability (abstr). PACE Pacing Clin Electrophysiol. 21 :887.
  • Weiss R, London B, McNamara DG, Shusterman V, Buetikofer JA, Brode S,...Anderson KP. (1998). Familial occurrence of right bundle branch block, ST elevation and arrhythmia susceptibility (abstr). PACE Pacing Clin Electrophysiol. 21 :939.
  • Shusterman V, Aysin B, Beigel A, Brode S, Fahrig S, Gottipaty V,...Anderson KP. (1998). Do slow variations in heart rate predict spontaneous initiation of ventricular tachycardia? PACE Pacing Clin Electrophysiol. 21 :948.
  • Schwartzman D, Michele JJ, Trankiem CT, Ren JF, Gottipaty V, Anderson KP. (1998). Radiofrequency energy titration for atrial ablation: prospective comparison of thermometry versus electrogram amplitude reduction (abstr). PACE Pacing Clinical Electrophysiol. 21 :849.
  • Hunn RH, Ashbaugh TJ, Calderini M, Anderson KP. (1998 June). Multiple inappropriate shocks precipitated by interrogation of an implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 21(6):1329-1330.
    PubMed ID: 9633083
  • Shusterman V, Aysin B, Gottipaty V, Weiss R, Brode S, Schwartzman D, Anderson KP. (1998 December). Autonomic nervous system activity and the spontaneous initiation of ventricular tachycardia. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring Trial. J Am Coll Cardiol. 32(7):1891-1899.
    PubMed ID: 9857869
  • Shusterman V, Aysin B, Shah IS, Flanigan S, Anderson KP. (1998). Autonomic nervious system effects on ventricular repolarization and RR interval variability during head-up tilt. Computers in Cardiology. 25 :717-720.
  • Brode S, Singh B, Anderson KP. (1998). Sotalol. Cardiac Electrophysiol Rev. 2 :211-214.
  • Brode S, Anderson KP. (1998). Moricizine. Cardiac Electrophysiol Rev. 2 :197-199.
  • Schwartzman D, Fischer DJ, Spencer EP, Anderson KP. (1998). Linear radiofrequency atrial lesions deployed using an irrigated electrode: electrical and histological evolution (abstr). CIRCULATION. 98 (Supp) :1567-68.
  • Anderson KP, Shusterman V, Aysin B, Brode S, Gottipaty V, Schwartzman D. (1998). Mismatch of tonic and phasic sympathetic activity precedes spontaneous ventricular tachycardia. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 31(90A)
  • Anderson KP, Shusterman V, Aysin B, Weiss R, Brode S, Gottipaty V. (1999 July). Distinctive RR dynamics preceding two modes of onset of spontaneous sustained ventricular tachycardia. (ESVEM) Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring. J Cardiovasc Electrophysiol. 10(7):897-904.
    PubMed ID: 10413369
  • Anderson KP, Shusterman V, Brode S, Gottipaty V, Schwartzman D, Weiss R. (1999). Noninvasive testing for selection of patients for electrophysiologic study. Ann Noninvasive Electrocardiol. 4 :434-442.
  • Shusterman V, Beigel A, Shah IS, Aysin B, Weiss R, Gottipaty V,...Anderson KP. (1999). Changes in autonomic activity and ventricular repolarization. J Electrocardiol. 32 :185-192.
  • Gold MR, Bloomfield DM, Anderson KP, El-sherif NE, Wilber DJ, Groh WJ,...Rosenbaum DS. (2000 December). A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol. 36(7):2247-2253.
    PubMed ID: 11127468
  • Shusterman V, Shah SI, Beigel A, Anderson KP. (2000 April). Enhancing the precision of ECG baseline correction: selective filtering and removal of residual error. Comput Biomed Res. 33(2):144-160.
    PubMed ID: 10854121
  • Kadish A, Quigg R, Schaechter A, Anderson KP, Estes M, Levine J. (2000 March). Defibrillators in nonischemic cardiomyopathy treatment evaluation. Pacing Clin Electrophysiol. 23(3):338-343.
    PubMed ID: 10750134
  • Shusterman V, Aysin B, Weiss R, Brode S, Gottipaty V, Schwartzman D, Anderson KP. (2000 January). Dynamics of low-frequency R-R interval oscillations preceding spontaneous ventricular tachycardia. Am Heart J. 139(1 Pt 1):126-133.
    PubMed ID: 10618573
  • Anderson KP. (2000). Pharmacologic therapy of ventricular tachycardia: management of cardiac arrhythmias. Humana Press. :331-357.
  • Anderson KP, Shusterman V, Flanigan S. (2000). Holter Monitoring. Atlas of Office Procedures: Cardiovascular Diseases. 3 :335-352.
  • Anderson KP, Vidaillet HJ, Josephson ME. (2001 October). A gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med. 345(14):1063-1064.
    PubMed ID: 11586962
  • Anderson KP. (2001 September). Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med. 345(11):837; author reply 838-839.
    PubMed ID: 11556310
  • Shusterman V, Aysin B, Anderson KP, Beigel A. (2001 April). Multidimensional rhythm disturbances as a precursor of sustained ventricular tachyarrhythmias. Circ Res. 88(7):705-712.
    PubMed ID: 11304493
  • Hayes JJ, Anderson KP, Sharma PP, Smith PN, Vidaillet HJ, Maassen KA. (2002). Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. JAMA. 288(24):3115-3123.
  • Anderson KP. (2003 December). The future of cardiac electrophysiology review. Cardiac Electrophysiol Rev. 7(4):311.
    PubMed ID: 15168682
  • Anderson KP. (2003 January). Sympathetic nervous system activity and ventricular tachyarrhythmias: recent advances. Ann Noninvasive Electrocardiol. 8(1):75-89.
    PubMed ID: 12848817
  • Anderson KP. (2003 July). Lipid-lowering therapy for prevention of ventricular tachyarrhythmias. J Am Coll Cardiol. 42(1):88-92.
    PubMed ID: 12849665
  • Sharma PP, Osorio HJ, Greenlee RT, Hayes JJ, Smith PN, Anderson KP, Vidaillet HJ. (2003). Prevalence of patients with myocardial infarction and reduced left ventricular ejection fraction: impact of the MADIT II study in the general population. J Am Coll Cardiol. 41(6 Suppl):96A.
  • Sharma PP, Greenlee RT, Hayes JJ, Smith PN, Anderson KP, Vidaillet HJ. (2004). How many patients with ischemic cardiomyopathy in the U.S. are eligible for ICD placement? Impact of the new CMS Coverage Guidelines. Heart Rhythm Society Annual Scientific Sessions. Heart Rhythm. 1(1S):S180-181.
  • Sharma PP, Greenlee RT, Hayes JJ, Anderson KP, Vidaillet HJ. (2004 November). Generalizability of the MADIT II trial: comparison of study participants versus eligible patients in a general population. CIRCULATION. 110(17):III827.
  • Kadish A, Dyer A, Daubert JP, Quigg R, Estes NMark, Anderson KP,...for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) investigators. (2004 May). Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. New Engl J Med. 350(21):2151-2158..
    PubMed ID: 15152060
  • Passman R, Anderson KP, Subacius H, Schaechter A, Howard A, Calkins H, Kadish A. (2004). For the DEFINITE investigators superior quality of life in patients with nonischemic dilated cardiomyopathy and implantable cardioverter-defibrillators: results from the DEFINITE study. CIRCULATION. 110 :III-625.
  • Anderson KP. (2005 November). Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government. J Interv Card Electrophysiol. 14(2):71-78.
    PubMed ID: 16374553
  • Kadish A, Schaechter A, Subacius H, Thattassery E, Sanders WE, Anderson KP,...Levine J. (2006 June). Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators. J Am Coll Cardiol. 47(12):2477-2482.
    PubMed ID: 16781376
  • Sharma PP, Greenlee RT, Anderson KP, Chyou P, Osorio HJ, Smith PN,...Vidaillet HJ [including Hayes JJ.] (2007 September). Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: Relation to the second multicenter automatic defibrillator implantation trial. J Interv Card Electrophysiol. 19(3):157-164.
    PubMed ID: 17805953
  • Anderson KP. (2007 September). Risk assessment for defibrillator therapy: Il Trittico. J Am Coll Cardiol. 50(12):1158-1160.
    PubMed ID: 17868807
  • Anderson KP. (2008 August). The changing epidemiology of ventricular arrhythmias. CARDIOLOGY CLINICS. 26(3):321-333.
    PubMed ID: 18538182
  • Anderson KP. (2009 October). Health status assessment tools: natural components of cardiac resynchronization therapy? Pacing Clin Electrophysiol. 32(10):1257-8.
    PubMed ID: 19732356
  • Anderson KP. (2009 March). Estimates of implantable cardioverter-defibrillator complications; caveat emptor. CIRCULATION. 119(8):1069-71.
    PubMed ID: 19255352
  • Anderson KP. (2011 February). Closing the gaps in atrial fibrillation ablation: the role of protected electrical connections. J Cardiovasc Electrophysiol.. 22(2):160-2.
    PubMed ID: 21040097
  • Anderson KP. (2012 August). Ablation for atrial fibrillation: what are acceptable levels of experience, efficacy, and complications? J Interv Card Electrophysiol. 34(2):125-8.
    PubMed ID: 22403043
  • Anderson KP. (2012 December). Prevention of Arrhythmic Death in Valvular Heart Disease: Beware the Implantable Defibrillator Paradox. J Cardiovasc Electrophysiol.. 23(12):1333-5.
    PubMed ID: 22882158
  • Anderson KP. (2012 January). Programmed electrical stimulation for risk assessment in brugada syndrome time to change the guidelines? JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 59(1):46-8.
    PubMed ID: 22192667
  • Anderson KP. (2014 April). Biological Clocks and Ventricular Tachyarrhythmias. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2(14):S0735-1097.
    PubMed ID: 24747103